Series A - Lipidio Pharmaceuticals
Investment Firm
Overview
Lipidio Pharmaceuticals focuses on advancing a molecule to treat diseases associated with excess body fat.
Announced Date
Nov 10, 2022
Funding Type
Series A
Highlights
Location
United States, North America
Social
Investor Lead
N/A
Participant Investors
2
| Investor Name |
|---|
 John Maraganore |
Round Details and Background
Lipidio Pharmaceuticals raised $20000000 on 2022-11-10 in Series A
Lipidio Pharmaceuticals focuses on advancing a molecule to treat diseases associated with excess body fat.
Company Funding History
2
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Mar 03, 2020 |  Series A - Lipidio Pharmaceuticals | 3 | - | undefined |
| Nov 10, 2022 | Series A - Lipidio Pharmaceuticals | 2 | - | 20.0M |
Recent Activity
There is no recent news or activity for this profile.